aod9604 dosage recommendations December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting PDF) Peptides: AOD-9604 & BPC-157

The peptide activates antioxidant response elements (ARE genes) in the nucleus, adding a protective layer against oxidative damage

Dose-response studies: Test multiple dose levels (e.g., 300, 500, 1000 mcg daily) Include a placebo control group Randomize subjects to dose groups Track both efficacy and safety endpoints Use standardized assessment methods Duration studies: Short-term: 48 weeks to assess acute effects Medium-term: 812 weeks for sustained fat loss (most common) Long-term: 1224 weeks for maximum effects and long-term safety Combination studies: Can be combined with other metabolic peptides Consider potential synergies or interactions May use lower doses when combining compounds Track for additive effects or side effects Include single-agent control groups for comparison Tracking parameters: Body weight and body composition (DEXA, BIA, or circumference) Fat mass and lean mass changes Regional fat distribution (waist circumference, imaging) Metabolic markers (glucose, insulin, lipids) Safety parameters (see safety section) Subjective measures (energy, appetite, well-being) Special Considerations Fasting vs fed state: Research suggests AOD9604 may be more effective when administered in a fasted state

Second, its essential to understand that there can be significant quality differences between B12 suppliers, impacting the effectiveness of the B12, its duration in your system, and even its safety

Quality, identity, and purity depend entirely on the supplier

Overall Health : A persons overall health and the presence of any underlying medical conditions can affect the absorption and utilization of Vitamin B12

Its been used in weight loss plans ever after, despite debate over its effectiveness